Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China
· Delayed Price · Currency is CNY 5.74
0.00 (0.00%)
Apr 30, 2026, 12:54 PM CST
SHE:300158 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,678 | 2,783 | 2,948 | 3,607 | 3,665 | 5,028 | Upgrade
|
| Other Revenue | - | - | 23.6 | 19.37 | 63.98 | 66.1 | Upgrade
|
| Revenue | 2,678 | 2,783 | 2,971 | 3,626 | 3,729 | 5,094 | Upgrade
|
| Revenue Growth (YoY) | -9.03% | -6.33% | -18.06% | -2.75% | -26.80% | 5.07% | Upgrade
|
| Cost of Revenue | 1,306 | 1,390 | 1,812 | 1,830 | 1,894 | 2,058 | Upgrade
|
| Gross Profit | 1,371 | 1,393 | 1,159 | 1,796 | 1,834 | 3,036 | Upgrade
|
| Selling, General & Admin | 1,492 | 1,507 | 1,441 | 1,762 | 1,808 | 2,662 | Upgrade
|
| Research & Development | 176.94 | 179.9 | 349.79 | 189.43 | 178.11 | 218.73 | Upgrade
|
| Other Operating Expenses | -33.95 | -23.64 | 7.79 | -34.98 | -22.64 | 15.01 | Upgrade
|
| Operating Expenses | 1,645 | 1,663 | 1,793 | 1,896 | 1,949 | 2,887 | Upgrade
|
| Operating Income | -273.54 | -269.66 | -634.14 | -99.52 | -114.52 | 148.84 | Upgrade
|
| Interest Expense | -0.54 | - | -3.9 | -1.21 | -13.78 | -19.63 | Upgrade
|
| Interest & Investment Income | 7.01 | 10.78 | 47.64 | 54.67 | 60.7 | 2,959 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -0.13 | 0 | 0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -15.5 | -20.36 | -2.55 | -11.07 | 28.7 | -20.72 | Upgrade
|
| EBT Excluding Unusual Items | -282.57 | -279.23 | -593.08 | -57.12 | -38.9 | 3,068 | Upgrade
|
| Impairment of Goodwill | - | - | -24.74 | - | - | -0.49 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1.38 | 1.59 | -139.44 | 1.96 | 11.59 | 0.83 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.63 | -0.63 | 10.54 | 0 | -0.86 | -0.49 | Upgrade
|
| Asset Writedown | 0.53 | 0.66 | -18.77 | -7.62 | -0.94 | -13.15 | Upgrade
|
| Other Unusual Items | - | - | -549.54 | 25.09 | 23.84 | 61.62 | Upgrade
|
| Pretax Income | -281.29 | -277.62 | -1,315 | -37.69 | -5.28 | 3,116 | Upgrade
|
| Income Tax Expense | 23.99 | 25.46 | 17.92 | 10.18 | 51.72 | 506.49 | Upgrade
|
| Earnings From Continuing Operations | -305.28 | -303.09 | -1,333 | -47.87 | -57 | 2,610 | Upgrade
|
| Minority Interest in Earnings | 2.02 | 2.02 | 4.38 | 3.89 | 5.71 | 7.8 | Upgrade
|
| Net Income | -303.26 | -301.06 | -1,329 | -43.98 | -51.29 | 2,617 | Upgrade
|
| Net Income to Common | -303.26 | -301.06 | -1,329 | -43.98 | -51.29 | 2,617 | Upgrade
|
| Net Income Growth | - | - | - | - | - | 898.92% | Upgrade
|
| Shares Outstanding (Basic) | 1,001 | 1,004 | 1,024 | 1,028 | 1,028 | 1,027 | Upgrade
|
| Shares Outstanding (Diluted) | 1,001 | 1,004 | 1,024 | 1,028 | 1,028 | 1,027 | Upgrade
|
| Shares Change (YoY) | -0.73% | -1.91% | -0.38% | -0.02% | 0.04% | -0.01% | Upgrade
|
| EPS (Basic) | -0.30 | -0.30 | -1.30 | -0.04 | -0.05 | 2.55 | Upgrade
|
| EPS (Diluted) | -0.30 | -0.30 | -1.30 | -0.04 | -0.05 | 2.55 | Upgrade
|
| EPS Growth | - | - | - | - | - | 898.98% | Upgrade
|
| Free Cash Flow | -606.64 | -639.6 | -448.3 | -365.39 | -64.49 | 132.79 | Upgrade
|
| Free Cash Flow Per Share | -0.61 | -0.64 | -0.44 | -0.36 | -0.06 | 0.13 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 2.800 | Upgrade
|
| Dividend Growth | - | - | - | - | - | 3900.00% | Upgrade
|
| Gross Margin | 51.22% | 50.06% | 39.00% | 49.54% | 49.20% | 59.60% | Upgrade
|
| Operating Margin | -10.22% | -9.69% | -21.34% | -2.74% | -3.07% | 2.92% | Upgrade
|
| Profit Margin | -11.33% | -10.82% | -44.72% | -1.21% | -1.38% | 51.39% | Upgrade
|
| Free Cash Flow Margin | -22.66% | -22.98% | -15.09% | -10.08% | -1.73% | 2.61% | Upgrade
|
| EBITDA | -155.52 | -153.66 | -526.26 | 22.15 | 11.49 | 273.97 | Upgrade
|
| EBITDA Margin | -5.81% | -5.52% | -17.71% | 0.61% | 0.31% | 5.38% | Upgrade
|
| D&A For EBITDA | 118.02 | 115.99 | 107.88 | 121.68 | 126.01 | 125.13 | Upgrade
|
| EBIT | -273.54 | -269.66 | -634.14 | -99.52 | -114.52 | 148.84 | Upgrade
|
| EBIT Margin | -10.22% | -9.69% | -21.34% | -2.74% | -3.07% | 2.92% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 16.25% | Upgrade
|
| Revenue as Reported | - | - | 2,971 | 3,626 | 3,729 | 5,094 | Upgrade
|
| Advertising Expenses | - | - | 1.09 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.